Human Metabolome Technologies, Inc. (TYO:6090)
Japan flag Japan · Delayed Price · Currency is JPY
760.00
+4.00 (0.53%)
Feb 17, 2026, 9:12 AM JST

TYO:6090 Income Statement

Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
1,4301,4551,3451,2991,2231,124
Revenue Growth (YoY)
2.36%8.18%3.54%6.21%8.81%0.54%
Cost of Revenue
565533476440384318
Gross Profit
865922869859839806
Selling, General & Admin
488487459454486663
Research & Development
17717718118515898
Operating Expenses
673672649648648766
Operating Income
19225022021119140
Interest Expense
-2-2-2-2-2-1
Interest & Investment Income
1-----
Currency Exchange Gain (Loss)
-1-954464
Other Non Operating Income (Expenses)
4217201817
EBT Excluding Unusual Items
19424124023325360
Gain (Loss) on Sale of Investments
-7-7----23
Other Unusual Items
2735214914
Pretax Income
21426926123726251
Income Tax Expense
81318-48-5-7
Net Income
20625624328526758
Net Income to Common
20625624328526758
Net Income Growth
-22.26%5.35%-14.74%6.74%360.35%-
Shares Outstanding (Basic)
666666
Shares Outstanding (Diluted)
666666
Shares Change (YoY)
-2.88%-0.69%0.14%0.08%-0.05%0.70%
EPS (Basic)
35.8543.5941.1048.2645.259.84
EPS (Diluted)
35.8543.5941.1048.2645.259.84
EPS Growth
-19.96%6.08%-14.85%6.66%360.04%-
Free Cash Flow
26225203186182-60
Free Cash Flow Per Share
4.5338.3134.3331.5030.85-10.16
Dividend Per Share
15.00015.00015.00010.000--
Dividend Growth
--50.00%---
Gross Margin
60.49%63.37%64.61%66.13%68.60%71.71%
Operating Margin
13.43%17.18%16.36%16.24%15.62%3.56%
Profit Margin
14.41%17.59%18.07%21.94%21.83%5.16%
Free Cash Flow Margin
1.82%15.46%15.09%14.32%14.88%-5.34%
EBITDA
30335330629125595
EBITDA Margin
21.19%24.26%22.75%22.40%20.85%8.45%
D&A For EBITDA
11110386806455
EBIT
19225022021119140
EBIT Margin
13.43%17.18%16.36%16.24%15.62%3.56%
Effective Tax Rate
3.74%4.83%6.90%---
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.